US

Summit Therapeutics in up to $5 bln licensing deal for Akeso’s cancer therapy

Dec 6 (Reuters) – Summit Therapeutics Inc (SMMT.O) said on Tuesday it would license China-based Akeso Inc’s (9926.HK) experimental cancer therapy in a deal worth up to $5 billion, sending its shares up 57% in premarket trade. The deal involves an upfront payment of $500 million to Akeso, which will also be eligible for regulatory …

Summit Therapeutics in up to $5 bln licensing deal for Akeso’s cancer therapy Read More »

Wall Street slides in broad-based selloff on recession worries

Meta drops on report of EU concern over targeted ads Indexes down: Dow 0.92%, S&P 1.26%, Nasdaq 1.63% Dec 6 (Reuters) – Wall Street’s main indexes slid on Tuesday, led by declines in Meta Platforms and other technology stocks as investors worried about a longer rate-hike cycle despite warnings of a potential recession next year. …

Wall Street slides in broad-based selloff on recession worries Read More »

Trump tax fraud trial: Here’s what’s at stake as jury deliberations continue – National

It’s one nerd former President Donald Trump would rather not be associated with: the verdict sheet at his company’s criminal tax fraud trial. Deliberations are set to spill into a second day Tuesday as jurors weigh charges that the Trump Organization helped executives dodge personal income taxes on perks such as Manhattan apartments and luxury …

Trump tax fraud trial: Here’s what’s at stake as jury deliberations continue – National Read More »

Wall St falls after strong service-sector data feeds hawkish Fed fears

US service sector activity picks up in November Tesla slides on reports of production cut in China Indexes down: Dow 0.70%, S&P 0.98%, Nasdaq 1.12% Dec 5 (Reuters) – Wall Street’s main indexes fell on Monday after better-than expected service-sector activity added to jitters that the US Federal Reserve might continue on its aggressive policy …

Wall St falls after strong service-sector data feeds hawkish Fed fears Read More »

Asia shares bank on eventual China opening; oil earnings

https://tmsnrt.rs/2zpUAr4 China shares push higher, dollar slips More Chinese cities ease coronavirus controls Cap on Russia oil comes into effect, impact uncertain SYDNEY, Dec 5 (Reuters) – Asian shares extended their rally on Monday as investors hoped steps to unwind pandemic restrictions in China would eventually brighten the outlook for global growth and commodity demand, …

Asia shares bank on eventual China opening; oil earnings Read More »

NY Fed paper ties reverse repo surge to bank regulation change

Dec 2 (Reuters) – Persistently massive inflows of cash into a key Federal Reserve facility are in large part being driven by a bank liquidity regulation change from last year, a report from the New York Fed said Friday. The Fed’s facility offers what are called reverse repos, which allow eligible firms to park cash …

NY Fed paper ties reverse repo surge to bank regulation change Read More »

US FDA gives first-ever approval to fecal transplant therapy

Nov 30 (Reuters) – The US health regulator on Wednesday approved Switzerland-based Ferring Pharmaceuticals’ fecal transplant-based therapy to reduce the recurrence of a bacterial infection, making it the first therapy of its kind to be cleared in the United States. The therapy, Rebyota, targets Clostridium difficile, or C. difficile – a superbug responsible for infections …

US FDA gives first-ever approval to fecal transplant therapy Read More »

Mexico, US plan pitch by early 2023 to lure firms from abroad

MEXICO CITY, Dec 2 (Reuters) – Mexican Economy Minister Raquel Buenrostro and US Secretary of Commerce Gina Raimondo on Friday agreed to set out a plan by early 2023 for the relocation of companies from Asia to North America, Mexico’s government said. On her first visit to Washington since taking office in October, Buenrostro has …

Mexico, US plan pitch by early 2023 to lure firms from abroad Read More »

US FDA approves Rigel Pharma’s treatment for a type of leukemia

Dec 1 (Reuters) – Rigel Pharmaceuticals (RIGL.O) said on Thursday the US health regulator has approved its drug for the treatment of patients with a type of leukemia, sending its shares up 14% in extended trading. The Food and Drug Administration approved the drug, which will be sold under the brand Rezlidhia, for the treatment …

US FDA approves Rigel Pharma’s treatment for a type of leukemia Read More »

As the Fed plans to ‘raise and hold,’ new projections may show the cost

WASHINGTON, Dec 2 (Reuters) – New US Federal Reserve projections, issued later this month alongside an expected half-point interest rate increase, could show the central bank’s target rate headed toward levels last seen on the eve of the 2007 financial crisis, and will also reveal policymakers’ best guess of the fallout that will have for …

As the Fed plans to ‘raise and hold,’ new projections may show the cost Read More »